Ribavirin for Lassa fever postexposure prophylaxis

Emerg Infect Dis. 2010 Dec;16(12):2009-11. doi: 10.3201/eid1612.100994.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Lassa Fever / prevention & control*
  • Male
  • Medication Adherence*
  • Middle Aged
  • Post-Exposure Prophylaxis*
  • Retrospective Studies
  • Ribavirin / administration & dosage*
  • Ribavirin / adverse effects
  • Sierra Leone / epidemiology

Substances

  • Antiviral Agents
  • Ribavirin